Skip to main content
  • Login
Home

User menu

Mega menu

  • EASL.eu
  • Resources

    Resources

    • EASL Resources
      • All Resources
      • Basic Techniques in Experimental Hepatology at a Glance
      • Clinical Practice Guidelines
      • Congress Resources
      • COVID-19 Resources
      • EASL Molecular Tumour Boards
      • EASL Genetic Grand Round
      • EASL Policy Dialogues
      • EASL Quiz
      • ePosters
      • EASL DeepDive
      • EASL Journal Club
      • Nurses and AHPs
      • Online Courses
      • On-demand Webinars
      • Podcasts
      • Slide Decks
      • Webcasts
      • Webinars Calendar
    • EASL-Related Resources
      • EHC On-demand Webinar
      • ERN Rare-Liver On-demand Webinars
      • Baveno VII - Consensus Workshop
      • Baveno VII - Pediatric Research Workshop
    • Industry Resources
      • All Resources
      • Industry Symposia - EASL Monothematic Conference 2023
      • Industry Symposia - EASL Congress
      • Industry Symposia - EASL Liver Cancer Summit
      • Industry Symposia - EASL SLD Summit
      • GSK Resources
    • Patient Resources
      • All Resources
      • COVID-19 Resources
      • Documents
      • ePosters
      • Infographics
      • Patient Guidelines
      • Podcasts
      • Slide Decks
      • Takeaways
      • Webcasts
  • EASL Studio
  • EASL Campus Connect
    • My Community
    • Explore Community
      • EASL Community Feed
      • All Topics
      • Community FAQ's
    • Create
  • Our Sponsors

EASL Community Feed

Get the latest news from the EASL Community

Newest topics

Hepatitis C Point of Care Testing
Gavin Hooper-Newton · 6 Feb
Welcome to EASL Campus Connect!
Elinam Gayi · 20 Jun
All topics

  • Viktoriia Hladun commented on Best of EASL Congress 2025 Slide…

    4 days ago
    Best of EASL Congress 2025 Slide Decks

    Best of EASL Congress 2025 Slide Decks

    Description The Best of EASL Congress 2025 Slide Decks bring together top selected abstracts from the Congress in a downloadable and editable PowerPoint format. These slides highlight the latest data presented at EASL Congress 2025 and are available for your personal use. Feel free to adapt and share them, but please acknowledge...
    Total amount of likes 4
    Total amount of comments 6
    Read more about Best of EASL Congress 2025 Slide Decks
    Log in to post comments
    Viktoriia Hladun
    Viktoriia Hladun • 4 days ago

    Many thanks to the congress organizers for the work done. Dr. Viktoriia Haldun

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous
    NGUYEN HUYEN NGUYEN • 6 days ago

    thank you so much!

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous
    Manuchehr Madvafoev
    Manuchehr Madvafoev • 1 week ago

    Thank you so much , I share this info with hepatologists of Tajikistan.
    Best of luck!

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous
    Leonard Sowah
    Leonard Sowah • 2 weeks ago

    Really interesting data on the NTCP-cotransporter blocker in HBV from Shanghai HEP Pharma Co. Ltd. in best of viral Hepatitis

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous
    Pedro Gaburri
    Pedro Gaburri • 2 weeks ago

    Congratulations for having shared this excellent EASL 2025 content. Thank you vey much.

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous
    Olha Shevchenko-Makarenko
    Olha Shevchenk… • 2 weeks ago

    Thank you very much for your work! Very informative and useful!
    Dr. Olha Sh-M

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Abdo Hezam commented on EASL Studio S8 E11: Interprofess…

    6 days ago
    EASL Studio S8 E11: Interprofessional Session: Implementing the New EASL MASLD Guidelines into Clinical Practice

    EASL Studio S8 E11: Interprofessional Session: Implementing the New EASL MASLD Guidelines into Clinical Practice

    Description Watch this EASL Studio episode for insights on the new MASLD guidelines and their practical application. Hear from experts on navigating the nomenclature change, implementing guidelines in clinical workflows, and fostering behavioral change to improve patient outcomes across the care team. Moderator: Sven Franc...
    Total amount of likes 1
    Total amount of comments 1
    Read more about EASL Studio S8 E11: Interprofessional Session: Implementing the New EASL MASLD Guidelines into Clinical Practice
    Log in to post comments
    Abdo Hezam
    Abdo Hezam • 6 days ago

    Thank you for best scientific sessions MASLD

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

  • EUNICE NUNES posted

    1 month ago

  • ABU SALEH MD SADEQUL ISLAM commented on ERN Rare-Liver on-demand Webinar…

    2 months ago
    ERN Rare-Liver on-demand Webinar: Contraception & Fertility in rare liver diseases

    ERN Rare-Liver on-demand Webinar: Contraception & Fertility in rare liver diseases

    Description This webinar, held on 17 December 2024, is a collaboration with the ERN RARE-LIVER Transition, Pregnancy, and Youth Panel groups. The session aims to highlight key challenges and explore specialised topics, including: What are the best contraception options for patients with liver disease? How can we prepare for...
    Total amount of likes 2
    Total amount of comments 2
    Read more about ERN Rare-Liver on-demand Webinar: Contraception & Fertility in rare liver diseases
    Log in to post comments
    ABU SALEH MD S… • 2 months ago

    Excellent

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous
    ABU SALEH MD S… • 2 months ago

    Excellent

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Sofia Damachi commented on TEST

    2 months ago

  • Antonio Aguilar Muñiz commented on The role of vascular biology in…

    3 months ago

  • Christian Molina-Aguilar posted

    8 months ago

  • Margaret Vernon commented on EASL Studio - Deciphering the dr…

    9 months ago

    EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention (Complete Session)

    EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention   Debbie Shawcross (Moderator), Paolo Angeli (Faculty), Salvador Augustin (Boehringer Ingelheim representative), Paolo Caraceni (CSL Behring representative) This EASL Studio is supported by Boehr...
    Total amount of likes 0
    Total amount of comments 2
    Read more about EASL Studio - Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention (Complete Session)
    Log in to post comments
    Margaret Vernon
    Margaret Vernon • 9 months ago

    Excellent discussion - very informative - thank you

    Like
    1 like
    Dislike 0
    Reply
    Anonymous
    Margaret Vernon
    Margaret Vernon • 9 months ago

    Excellent discussion - very informative - thank you

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Luis Rodriguez commented on TIPS and ascites (Complete Sessi…

    10 months ago

  • ABU SALEH MD SADEQUL ISLAM commented on Non-alcoholic fatty liver diseas…

    11 months ago
    Non-alcoholic fatty liver disease: A patient guideline

    Non-alcoholic fatty liver disease: A patient guideline

    This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which ha...
    Total amount of likes 2
    Total amount of comments 1
    ABU SALEH MD S… • 11 months ago

    EASY LANGUAGE

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

  • ABU SALEH MD SADEQUL ISLAM commented on Liver Cancer Explained

    11 months ago
    Liver Cancer Explained

    Liver Cancer Explained

    Liver cancer is the third leading cause of cancer-related deaths worldwide and the primary cause of death for patients with cirrhosis. Most of liver cancers are hepatocellular carcinomas, however some patients develop intrahepatic cholangiocarcinomas (ICC) or rare tumours in non-cirrhotic livers. Chronic liver diseases, alcohol c...
    Total amount of likes 1
    Total amount of comments 1
    ABU SALEH MD S… • 11 months ago

    EXCELLENT SUMMARIZE

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

  • ABU SALEH MD SADEQUL ISLAM commented on ILC 2021 Takeaways – Public heal…

    11 months ago
    ILC 2021 Takeaways – Public health

    ILC 2021 Takeaways – Public health

    As part of the International Liver Congress (ILC) 2021, the EASL Takeaways take a look at key topics from the congress, with leading experts discussing the most impactful science and putting it into perspective. This session, presented by Professors Maria Buti, Shira Zelber-Sagi and Antonio Craxì, explores prominent themes f...
    Total amount of likes 1
    Total amount of comments 1
    Read more about ILC 2021 Takeaways – Public health
    Log in to post comments
    ABU SALEH MD S… • 11 months ago

    EXCELLENT DISCUSSION

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

  • 元春 刘 posted

    11 months ago

  • LUIZ OTAVIO Cangussu posted

    11 months ago

  • LUIZ OTAVIO Cangussu posted

    11 months ago

  • ABU SALEH MD SADEQUL ISLAM commented on EASL Clinical Practice Guideline…

    11 months ago
    EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

    EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

    Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or pre-existing, liver diseases in pregnancy are associated with a significant risk of maternal and fetal morbidity and mortality. Thus, the European Ass...
    Total amount of likes 0
    Total amount of comments 1
    ABU SALEH MD S… • 11 months ago

    EXCELLENT

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

  • Rehana Begum commented on Mycophenolate Mofetil as first l…

    11 months ago

  • Vincenzo Mazzaferro commented on EASL Studio - Advances in system…

    11 months ago

    EASL Studio - Advances in systemic treatments in liver cancer (Complete Session)

    EASL Studio - Advances in systemic treatments in liver cancer   Josep Llovet (Moderator), Massimo Iavarone (Faculty), Matthias Pinter (Faculty), Jessica Zucman-Rossi (Faculty)
    Total amount of likes 0
    Total amount of comments 1
    Read more about EASL Studio - Advances in systemic treatments in liver cancer (Complete Session)
    Log in to post comments
    Vincenzo Mazzaferro
    Vincenzo Mazzaferro • 11 months ago

    😊

    Like
    1 like
    Dislike 0
    Reply
    Anonymous

  • mohamed abdiaziz posted

    1 year ago

  • Rahim Khan commented on EASL Studio S6 E12: Do we care e…

    1 year ago
    EASL Studio S6 E12: Do we care enough about the importance of DILI/DHILI ?

    EASL Studio S6 E12: Do we care enough about the importance of DILI/DHILI ?

    Description Join us for a critical discussion on the significance of Drug and Herbal & Dietary Supplement-Induced Liver Injury (DHILI). In this episode, the speakers explore the importance of DHILI, assess recent advancements, and deliberate on the obstacles hindering further progress in addressing this pressing healthcare c...
    Total amount of likes 0
    Total amount of comments 1
    Read more about EASL Studio S6 E12: Do we care enough about the importance of DILI/DHILI ?
    Log in to post comments
    Rahim Khan
    Rahim Khan • 1 year ago

    Can I discuss a case and get opinion's from expert when to consider liver biopsy ?

    Like
    0 likes
    Dislike 0
    Reply
    Anonymous

    • Pagination

    • Next page ››

Community Stream

Easl Community FeedMy Feed
Browse Stream
EASL.EU Home
Home of Hepatology
7 rue Daubin
1203 Geneva
Switzerland

Follow us:

Sign up to EASL News

©2019 - EASL. All Rights Reserved. Powered by Enovation.

Footer menu

  • Content Access policy
  • Privacy Policy
  • Cookie Policy